Serotonin receptor mechanisms mediate the discriminative stimulus properties of the atypical antipsychotic clozapine in C57BL/6 mice

Psychopharmacology

Volumn 180, Issue 1, 2005, Pages 49-56

  Philibin, Scott D ^a   Prus, Adam J ^a   Pehrson, Alan L ^a   Porter, Joseph H ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Amphetamine; Antipsychotic drugs; Drug discrimination; Haloperidol; Olanzapine; Quipazine; Risperidone; Ritanserin; Schizophrenia; Scopolamine; Serotonin; Ziprasidone

Indexed keywords

AMPHETAMINE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; MUSCARINIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; OLANZAPINE; QUIPAZINE; RISPERIDONE; RITANSERIN; SCOPOLAMINE; SEROTONIN 2A ANTAGONIST; SEROTONIN 2B RECEPTOR; SEROTONIN 2C ANTAGONIST; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; BEHAVIOR; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DRUG DISCRIMINATION; DRUG SCREENING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRAINING;

ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C57BL; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; RECEPTORS, SEROTONIN, 5-HT2; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 18044399063     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-2147-0     Document Type: Article

References (36)

1. Bond NW (1988) Ontogeny of activity in inbred and random-bred strains of mice: effects of scopolamine. Behav Neurosci 102 (6):887-893
2. Bruhwyler J, Liegeois JF, Bergman J, Carey G, Goudie A, Taylor A, Meltzer H, Delarge J, Geczy J (1997) JL13, a pyridobenzoxazepine compound with potential atypical antipsychotic activity: a review of its behavioural properties. Pharmacol Res 36:255-264
3. Carey GJ, Bergman J (1997) Discriminative-stimulus effects of clozapine in squirrel monkeys: comparison with conventional and novel antipsychotic drugs. Psychopharmacology (Berl) 132:261-269
4. 2A antagonist, MDL100,907. Neuropharmacology 44:604-615
5. Estape N, Steckler T (2002) Cholinergic blockade impairs performance in operant DNMTP in two inbred strains of mice. Pharmacol Biochem Behav 72:319-334
6. Extance K, Goudie AJ (1981) Inter-animal olfactory cues in operant drug discrimination procedures in rats. Psychopharmacology (Berl) 73:363-371
7. Fiorella D, Helsley S, Rabin RA, Winter JC (1997) Further investigations of the interactions of antipsychotics with the (-) 2,5-dimethoxy-4- methylamphetamine (DOM) discriminative stimulus. Neuropharmacology 36:1463-1469
8. Friedman RL, Barrett RJ, Sanders-Bush E (1984) Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites. J Pharmacol Exp Ther 228(3):628-635
9. Geyer MA, Ellenbroek B (2003) Animal behavior models of the mechanisms underlying antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry 27:1071-1079
10. Glennon RA (1986) Discriminative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI). Life Sci 39(9):825-830
11. Glennon RA, Young R, Rosecrans JA (1983) Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists. Eur J Pharmacol 91 (2-3):189-196
12. Goas JA, Boston JE Jr (1978) Discriminative stimulus properties of clozapine and chlorpromazine. Pharmacol Biochem Behav 8:235-241
13. Gold LH (1996) Integration of molecular biological techniques and behavioural pharmacology. Behav Pharmacol 7:589-615
14. Goudie AJ, Smith JA (1999) Discriminative stimulus properties of antipsychotics. Pharmacol Biochem Behav 64(2):193-201
15. Goudie A, Taylor A (1998) Comparative characterisation of the discriminative stimulus properties of clozapine and other antipsychotics in rats. Psychopharmacology (Berl) 135:392-400
16. Goudie AJ, Smith JA, Taylor A, Taylor MA, Tricklebank MD (1998) Discriminative stimulus properties of the atypical neuroleptic clozapine in rats: tests with subtype selective receptor ligands. Behav Pharmacol 9:699-710
17. Goudie AJ, Smith JA, Millan MJ (2004) Characterization of the effects of receptor-selective ligands in rats discriminating the novel antipsychotic quetiapine. Psychopharmacology 171:212-222
18. Hoenicke EM, Vanecek SA, Woods JH (1992) The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors. J Pharmacol Exp Ther 263:276-284
19. Kelley BM, Porter JH (1997) The role of muscarinic cholinergic receptors in the discriminative stimulus properties of clozapine in rats. Pharmacol Biochem Behav 57:707-719
20. i values. J Pharmacol Exp Ther 251:238-246
21. Meltzer HY, Li Z, Kaneda Y, Ichikawa J (2003) Serotonin receptors: their key role in drugs to treat schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 27:1159-1172
22. Millan MJ, Schreiber R, Dekeyne A, Rivet JM, Bervoets K, Mavridis M, Sebban C, Maurel-Remy S, Newman-Tancredi A, Spedding M, Muller O, Lavielle G, Brocco M (1998) S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties. II. Functional profile in comparison to clozapine and haloperidol. J Pharmacol Exp Ther 286:1356-1373
23. Millan MJ, Schreiber R, Monneyron S, Denorme B, Melon C, Queriaux S, Dekeyne A (1999) S-16924 a novel, potential antipsychotic with marked serotonin 1a agonist properties. IV. A drug discrimination comparison with clozapine. J Pharmacol Exp Ther 289:427-436
24. Millan MJ, Brocco M, Rivet JM, Audinot V, Newman-Tancredi A, Maiofiss L, Queriaux S, Despaux N, Peglion JL, Dekeyne A (2000) S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha (1)- and alpha(2)-adrenergic receptors. II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents. J Pharmacol Exp Ther 292:54-66
25. Moore NA, Tye NC, Axton MS, Risius FC (1992) The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent. J Pharmacol Exp Ther 262:545-551
26. Nielsen EB (1988) Cholinergic mediation of the discriminative stimulus properties of clozapine. Psychopharmacology (Berl) 94:115-118
27. Oliverio A, Eleftheriou BE, Bailey DW (1973) Exploratory activity: genetic analysis of its modification by scopolamine and amphetamine. Physiol Behav 10(5):893-899
28. Porter JH, Varvel SA, Vann RE, Philibin SD, Wise LE (2000) Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats. Psychopharmacology (Berl) 149:189-193
29. Porter JH, Prus AJ, Vann RE, Varvel SA (2004) Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in rats. Psychopharmacology (Berl) DOI 10.1007/s00213-004-1985-5 online first
30. Prus AJ, Baker LE, Meltzer HY (2004) Discriminative stimulus properties of 1.25 mg/kg and 5.0 mg/kg doses of clozapine in rats: further examination of the role of dopamine, serotonin and muscarinic receptor mechanisms. Pharmacol Biochem Behav 77(2):199-208
31. Schotte A, Janssen PF, Gommeren W, Luyten WH, Van Gompel P, Lesage AS, De Loore K, Leysen JE (1996) Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology (Berl) 124:57-73
32. Seeman P (2002) Atypical antipsychotics: mechanism of action. Can J Psychiatry 47:27-38
33. Smith RL, Barrett RJ, Sanders-Bush E (1995) Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor. J Pharmacol Exp Ther 275(2):1050-1057
34. Smith RL, Barrett RJ, Sanders-Bush E (2003) Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/-)DOI] in C57BL/6J mice. Psychopharmacology (Berl) 166(1):61-68
35. Tang AH, Franklin SR, Himes CS, Smith MW, Tenbrink RE (1997) PNU-96415E, a potential antipsychotic agent with clozapinelike pharmacological properties. J Pharmacol Exp Ther 281:440-447
36. Wiley JL, Porter JH (1992) Serotonergic drugs do not substitute for clozapine in clozapine-trained rats in a two-lever drug discrimination procedure. Pharmacol Biochem Behav 43:961-965